NEW YORK (GenomeWeb News) – Scientists at the Icahn School of Medicine at Mount Sinai will use $5 million in funding from the National Institute on Deafness and Other Communication Disorders to correlate genetic factors and brain structure to identify, diagnose, and treat a vocal cord disorder that impairs speech.

The researchers are focused on understanding spasmodic dysphonia, a disorder arising in mid-life that causes interruptions in speech and can cause the voice to break up or sound strained but does not damage vocal cords or the throat.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: swapping yeast genes with human orthologs to study conservation of function, and more.

Hong Kong is using DNA phenotyping to shame litterers.

A study appearing in Cell suggests some metastatic castration-resistant prostate cancer patients could benefit from PARP inhibitor therapy.

NIH's Francis Collins writes that scientific advances are poised to help populations all over the world, but more scientists are needed to keep the momentum.